相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Percutaneous coronary intervention for stable coronary artery disease
Demosthenes G. Katritsis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
Stephen D. Wiviott et al.
LANCET (2008)
CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease
Muhammad Rizvi et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation
Domenico Ferro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin
P. Pignatelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
Eric L. Eisenstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The clinical implications of increased coexpression of CD40-CD40 ligand system and C-reactive protein in patients after percutaneous coronary intervention
Jin-Chuan Yan et al.
CLINICA CHIMICA ACTA (2006)
Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction
Patrick Ohlmann et al.
AMERICAN HEART JOURNAL (2006)
NADPH oxidases in cardiovascular health and disease
Alison C. Cave et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus
F Santilli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension
MP Schneider et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Vitamin C inhibits platelet expression of CD40 ligand
P Pignatelli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia
V Sanguigni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers
SA Harding et al.
CIRCULATION (2004)
Vitamin C pharmacokinetics: Implications for oral and intravenous use
SJ Padayatty et al.
ANNALS OF INTERNAL MEDICINE (2004)
gp91phox-dependent expression of platelet CD40 ligand
P Pignatelli et al.
CIRCULATION (2004)
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses - Results from the sirolimus-eluting balloon expandable stent in the treatment of patients with de novo native coronary artery lesions (SIRIUS) trial
DJ Cohen et al.
CIRCULATION (2004)
Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a) - Short-term and long-term immunologic responses to oxidized low-density lipoprotein
S Tsimikas et al.
CIRCULATION (2004)
Reoxygenation-induced constriction in murine coronary arteries -: The role of endothelial NADPH oxidase (gp91phox) and intracellular superoxide
JQ Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of TNF receptor-associated factor 3 in the CD40 signaling by production of reactive oxygen species through association with p40(phox), a cytosolic subunit of nicotinamide adenine dinucleotide phosphate oxidase
YJ Ha et al.
JOURNAL OF IMMUNOLOGY (2004)
Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography - A comparison of blood-borne isoprostane and troponin release
K Berg et al.
FREE RADICAL RESEARCH (2004)
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty
F Cipollone et al.
CIRCULATION (2003)
Soluble CD40L -: Risk prediction after acute coronary syndromes
N Varo et al.
CIRCULATION (2003)
Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery
GM Jacobson et al.
CIRCULATION RESEARCH (2003)
Soluble CD40 ligand in acute coronary syndromes
C Heeschen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells
U Schönbeck et al.
CIRCULATION (2002)
Angioplasty increases coronary sinus F-2-isoprostane formation: Evidence for in vivo oxidative stress during PTCA
L Iuliano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
分享论文
